175 related articles for article (PubMed ID: 37669022)
1. Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy.
Lee YM; Hsu CL; Chen YH; Ou DL; Hsu C; Tan CT
Cancer Immunol Res; 2023 Nov; 11(11):1553-1567. PubMed ID: 37669022
[TBL] [Abstract][Full Text] [Related]
2. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
3.
Shi Y; Ren X; Cao S; Chen X; Yuan B; Brasil da Costa FH; Rodriguez Rosario AE; Corona A; Michikawa C; Veeramachaneni R; Osman AA; Xie T; Wang W; Sikora AG; Myers JN; Rangel R
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604640
[TBL] [Abstract][Full Text] [Related]
4. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
5. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
[TBL] [Abstract][Full Text] [Related]
7. 4NQO induced carcinogenesis: A mouse model for oral squamous cell carcinoma.
Sagheer SH; Whitaker-Menezes D; Han JYS; Curry JM; Martinez-Outschoorn U; Philp NJ
Methods Cell Biol; 2021; 163():93-111. PubMed ID: 33785171
[TBL] [Abstract][Full Text] [Related]
8. Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY; Lim KP; Cheong SC
Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510
[TBL] [Abstract][Full Text] [Related]
9. Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma.
Monteiro de Oliveira Novaes JA; Hirz T; Guijarro I; Nilsson M; Pisegna MA; Poteete A; Barsoumian HB; Fradette JJ; Chen LN; Gibbons DL; Tian X; Wang J; Myers JN; McArthur MJ; Bell D; William WN; Heymach JV
Cancer Prev Res (Phila); 2021 Mar; 14(3):313-324. PubMed ID: 33277316
[TBL] [Abstract][Full Text] [Related]
10. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
[TBL] [Abstract][Full Text] [Related]
11. An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation.
Fu Y; Tian G; Li J; Zhang Z; Xu K
Int J Mol Med; 2020 Oct; 46(4):1501-1513. PubMed ID: 32700748
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
[TBL] [Abstract][Full Text] [Related]
13. NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma.
Hamad SH; Sellers RS; Wamsley N; Zolkind P; Schrank TP; Major MB; Weissman BE
Cancer Res Commun; 2024 Feb; 4(2):487-495. PubMed ID: 38335300
[TBL] [Abstract][Full Text] [Related]
14. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared-II Ag
Xiong H; Shao S; Yang Y; Wang W; Xiong H; Han Y; Wang Z; Hu X; Zeng L; Yang Z; Su T
Biomed Pharmacother; 2024 Jan; 170():116011. PubMed ID: 38157644
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-induced HSF1-HSP90 axis enhances the expression of functional PD-L1 in oral squamous cell carcinoma.
Sasaya T; Kubo T; Murata K; Mizue Y; Sasaki K; Yanagawa J; Imagawa M; Kato H; Tsukahara T; Kanaseki T; Tamura Y; Miyazaki A; Hirohashi Y; Torigoe T
Cancer Med; 2023 Feb; 12(4):4605-4615. PubMed ID: 36200687
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma.
Shi Y; Xie T; Wang B; Wang R; Cai Y; Yuan B; Gleber-Netto FO; Tian X; Rodriguez-Rosario AE; Osman AA; Wang J; Pickering CR; Ren X; Sikora AG; Myers JN; Rangel R
Commun Biol; 2022 Jul; 5(1):757. PubMed ID: 35902768
[TBL] [Abstract][Full Text] [Related]
18. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
[TBL] [Abstract][Full Text] [Related]
19. A Spatial Transcriptome Reveals Changes in Tumor and Tumor Microenvironment in Oral Cancer with Acquired Resistance to Immunotherapy.
Iwasa YI; Nakajima T; Hori K; Yokota Y; Kitoh R; Uehara T; Takumi Y
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136558
[TBL] [Abstract][Full Text] [Related]
20. Microneedle-mediated Intratumoral Delivery of Anti-CTLA-4 Promotes cDC1-dependent Eradication of Oral Squamous Cell Carcinoma with Limited irAEs.
Gilardi M; Saddawi-Konefka R; Wu VH; Lopez-Ramirez MA; Wang Z; Soto F; Ramms DJ; Proietto M; Mikulski Z; Miki H; Sharabi A; Kupor D; Rueda R; Hollern DP; Wang J; Gutkind JS
Mol Cancer Ther; 2022 Apr; 21(4):616-624. PubMed ID: 35086958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]